Result Summary for 105517/396
| Protocol ID: | 105517/396 |
| Clinical Study ID: | 105517/396 |
| Official Title: | A multicenter, open-label extension study to evaluate the safety of twice daily oral carvedilol in pediatric subjects with chronic heart failure (including results of Study 321 Open Label phase [321OL]) |
| Phase: | Phase 4 |
| Study Indications or Diseases: |
|
| Generic Name: | carvedilol |
| Trade/Product Name: | Coreg CR,Coreg |
| Approved Drug Label: | http://www.gsk.com/products.html |
| Results Summary: |  Click
here to download result summary. |
| Citations: |
|
The summaries are in PDF format. If you do not have Adobe® Acrobat® Reader™ installed, you can download it for free.
